Cystatin C and NGAL - the Markers of Preclinical Renal Dysfuction and Subclinical Acute Kidney Injury
Author:
- V. V. Vel'KovVVV. V. Vel'Kov
- 1 January 2015
- journal article
- Published by Media Sphere Publishing Group in Laboratory Service
- Vol. 4 (2)
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Occult chronic kidney disease among persons with hypertension in the United StatesJournal Of Hypertension, 2013
- Subclinical AKI—an emerging syndrome with important consequencesNature Reviews Nephrology, 2012
- Diagnostic and Prognostic Stratification in the Emergency Department Using Urinary Biomarkers of Nephron DamageJACC, 2012
- Cystatin C in Prediction of Acute Kidney Injury: A Systemic Review and Meta-analysisAmerican Journal of Kidney Diseases, 2011
- The Outcome of Neutrophil Gelatinase-Associated Lipocalin-Positive Subclinical Acute Kidney InjuryJACC, 2011
- Accuracy of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Diagnosis and Prognosis in Acute Kidney Injury: A Systematic Review and Meta-analysisAmerican Journal of Kidney Diseases, 2009
- Cystatin C: Research Priorities Targeted to Clinical Decision MakingAmerican Journal of Kidney Diseases, 2008
- An assessment of the RIFLE criteria for acute renal failure in hospitalized patients*Critical Care Medicine, 2006
- Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized PatientsJournal of the American Society of Nephrology, 2005
- A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rateNephrology Dialysis Transplantation, 2003